Skip to main content

FDA lifts clinical hold on Peninsula company's off-the-shelf cancer cell therapy trial

The FDA three months ago placed a clinical hold on the company's cancer cell therapy trials after finding an "chromosomal abnormality."
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.